Jump to top menu Jump to main menu Jump to content
Department

Viroscience

Our mission is to limit the clinical and public outcomes of high-impact virus infections through an integrated field-to-bench-to-bedside research program.

About our department

Our research

About the department of Viroscience

The Department of Viroscience of the Erasmus MC is an international centre of excellence for multidisciplinary, basic, translational and clinical research of viruses and virus infections at the molecular, patient and population level. The unique aspect of the Department of Viroscience is its translational approach, with expertise ranging from basic virology to clinical virology, connecting medical and veterinary health, public health and ecology. By combining these complementary areas of expertise The Department of Viroscience is able to meet today's and tomorrow's societal challenges in diseases caused by common and newly emerging viruses.

Global impact of the department of Viroscience

  • Discovery of the human metapneumovirus MERS CoV, and othersThe identification of camels as the reservoir for MERS CoV
  • Basic insights into how avian in uenza viruses and other zoonoses cause diseases in humans
  • Unravelling how avian influenza viruses can become transmissible for humans
  • Discovery of mechanism of norovirus evolution and its impact on population health
  • Support to WHO as collaborating centre for emerging viral infections
  • And many more

About new emerging viral infections

Viral infections like Ebola, MERS and SARS continue to be among the leading causes of illness and death across the world. They threaten the health of the global population if they are not rapidly detected and contained.They threaten the health of the global population if they are not rapidly detected and contained. Besides known viruses, new viruses continue to emerge due to rapid demographic changes over the past decades, as well as globalization of travel and trade? Zika virus is a recent example. Vaccines may have been developed for known viruses, however ageing of the population, and treatment strategies of persons with complex comorbidities, such as an impaired immune system, have also led to novel challenges in prevention and treatment. Common viral infections may have a severe impact on these patients in terms of morbidity, quality of life and on a community level in health care cost.

The Department of Viroscience is Reference Centre  for:

  1. WHO Collaborating Centre (WHO-CC) – Emerging Viral Infections
  2. WHO National Reference Laboratory Centre - Measles & Rubella
  3. National Reference Centre for Influenza and Emerging Infections in The Netherlands

Reference Centers

The Department of Virology of the Erasmus MC is:

  1. WHO Collaborating Centre (WHO-CC) – Emerging Viral Infections
  2. WHO National Reference Laboratory Centre - Measles & Rubella
  3. National Reference Centre for Influenza and Emerging Infections in The Netherlands 

1. WHO Collaborating Centre (WHO-CC)

Main activity of the Department of Virology (Viroscience) of the Erasmus MC as WHO Collaborating Centre is to support outbreak response operations during outbreaks of Emerging and Dangerous Pathogens coordinated by WHO. Examples of this are the contributions of the department in identifying the cause of SARS and MERS coronavirus, the studies unraveling the role of camels as sources MERS COV, support in investigations of Zika virus in Surinam and Brazil, and the operation of mobile laboratories during the Ebola outbreak in West Africa.

The Department of Virology (Viroscience) uses classical and newly developed state-of-the-art technology to identify known or new viral pathogens. This is possible because the Department of Virology has a wide-array of serological and molecular tests to identify known pathogens. Random priming sequencing technology is also available for unknown agents.

During response operations to outbreaks of Emerging and Dangerous Pathogens coordinated by WHO, the Department of Virology will be contacted by WHO to provide onsite laboratory diagnostic support with staff and equipment when possible. The field deployment of lab equipment or staff will be coordinated with WHO and partners involved in control operations. Depending on incriminated pathogen, the Department of Virology will provide lab diagnostic technology to rapidly, safely and accurately diagnose patient and support Surveillance, Case management and research projects.

The Department of Virology also provides technical support to National laboratories by providing (in limited quantities) reagents and diagnostic methods to national reference laboratories.
The Department of Virology (Viroscience) is WHO Collaborating Centre regarding Viral infections on the following terms of reference:

  • To cooperate with WHO in its function of alert and response to outbreaks of Emerging and Dangerous Pathogens of international importance, including outbreaks of Arboviruses, Viral Haemorrhagic Fevers and novel and emerging infectious diseases.
  • Support WHO in the early diagnosis, rapid identification and characterization of high-risk pathogens specimens submitted through WHO, keeping the results confidential, if so required.
  • During response operations to outbreaks of Emerging and Dangerous Pathogens coordinated by WHO, to assist with epidemiological surveys carried out under the responsibility of WHO by providing personnel and/or equipment when possible.
  • During response operations to outbreaks of Emerging and Dangerous Pathogens coordinated by WHO, to provide onsite laboratory diagnostic support with staff and equipment when possible.
  • Provide technical support to the national laboratories involved in epidemiological and laboratory investigations during Emerging Infectious Diseases outbreak responses.
  • To inform WHO of any epidemiological or laboratory finding that would be in conjunction with a risk of transmission of a severe disease of international concern: Arboviruses, Viral Haemorrhagic Fevers and novel and emerging infectious diseases.

2. WHO National Reference Laboratory Centre - Measles & Rubella

The Department of Virology (Viroscience) of the Erasmus MC is accredited as National Reference Laboratory for Measles and Rubella, as part of the WHO European Measles and Rubella Laboratory Network. This responsibility is shared with the National Institute of Public Health and the Environment, Center for Infectious Disease research, Diagnostics and Screening. The objective of the laboratory network is to document and verify elimination of measles and rubella from the WHO European Region, based on procedures developed for certification of the global eradication of smallpox and poliomyelitis.

Measles, rubella and congenital rubella syndrome are preventable through immunization. The diseases are important causes of global morbidity and mortality. All countries in the WHO European Region include highly effective and safe measles and rubella vaccines in their vaccination program. However, due to persistent gaps in immunization coverage outbreaks of measles and rubella continue to occur.

The WHO National Reference Laboratories have two main responsibilities:

  • Case-based laboratory diagnosis of suspected measles and rubella cases, and reporting of confirmed cases to the surveillance system;
  • Genotyping of measles and rubella viruses, and reporting viral sequences to the surveillance systems MeaNS and RubeNS.

All WHO regions have elimination goals for measles and rubella. The criteria for the verification of measles elimination are documentation of the interruption of endemic measles and rubella for a period of more than 36 months in the presence of an adequate surveillance system that can detect import-related cases. This must be supplemented with genotyping data that support the interruption of endemic transmission.

These efforts should eventually lead to the ultimate goal of global eradication of measles and rubella.

3. National Reference Centre for Influenza and Emerging Infections in The Netherlands

The Department of Virology (Viroscience) is National Reference Centre for Influenza and Emerging Infections in the Netherlands.

Influenza surveillance Newsletters

You can find the Influenza Newsletters (in DUTCH): here

Want to sign up for the Infuenza surveillance nieuwsbrieven? Please, send an e-mail to: nic@erasmusmc.nl ( in DUTCH)

 

 

 

Research Lines

Research organization

Our research program has two main pillars:

  1. One health (research lines 1, 2, 3)

    As a result of world-wide changes in climate, land use, and animal management, there is an increased risk of zoonotic viruses crossing the species barrier, adapting to the human host, and gaining human-to-human transmissibility, resulting in novel epidemics or pandemics. The main goal of this research pillar is to provide the basic, translational and clinical research needed to develop evidence-based detection, prevention, treatment and intervention strategies against zoonotic viruses with potential to cause epidemics and pandemics.
  2. Personalised health (research lines 4, 5, 6, 7)

    Due to major demographic changes in our population, the group of high-risk patients (elderly, immuno-compromised, patients with complex co-morbidities, prematurely born children) is increasing, resulting in an increased burden of disease due to acute and chronic infections with a range of viruses. The main goal of this pillar is to improve detection, prevention and intervention strategies against such virus infections at the patient level.

Research line 1

Emerging Infectious disease research preparedness and response in a One Health context.

Research line 2:

Emerging disease (immune)pathogenesis, and medical countermeasures.

Research line 3:

Influenza virus ecology, evolution, pathogenesis, and public health impact

Research line 4:

Immunopathogenesis of paramyxoviruses and pneumoviruses

Research line 5:

NeuroImmune Biology of Virus Infections (NIMBUS)

Research line 6:

HIV and HCV

Research line 7: 

Clinical Virology

Laboratory for Calcium and Bone Metabolism

The overall aim of the research group is to understand the mechanisms behind skeletal disorders and discover novel therapeutic targets for the treatment of disturbances in bone and mineral homeostasis.

Viroscience: Clinical Virology

The overall aim of this research line is to improve diagnosis, triaging, monitoring and treatment for an increasing patient population at risk of complications due to a range of co-morbidities

Viroscience: Emerging disease (immune)pathogenesis, and medical countermeasures

The overall objective of this research line is to unravel key pathogenic pathways for selected EID as a basis for future interventions and medical countermeasures.

Viroscience: Emerging Infectious disease research preparedness and response in a One Health context

Overall objective is to reduce impact of emerging infectious diseases through development of risk based-prediction and early warning tools, state-of-the-art reference diagnostics, and rapid research response during outbreaks.

Viroscience: HIV and HCV

The pathogenesis, prevention and treatment of chronic viral infections.

Viroscience: Immunopathogenesis of paramyxoviruses and pneumoviruses

The overall aim of this research line is to understand the interaction of paramyxo- and pneumoviruses and the host in order to identify correlates of disease or protection, understand viral mechanisms of immune evasion, and use these insights to develop intervention strategies.

Viroscience: Influenza virus ecology, evolution, pathogenesis and public health impact

The overall objective of this research line is to reduce the impact of epidemic and pandemic influenza through research on viruses in reservoir hosts, transient hosts, and humans, and to develop mitigation strategies based on surveillance, vaccines and antivirals..

Viroscience: NeuroImmune Biology of Virus Infections (NIMBUS)

The overall aim of this research line is to decrease the impact of virus-induced neurological diseases through detailed knowledge of the complex tripartite interaction between viruses, the human nervous system and the immune system.

Principal Investigators

Projects

  • BARDA 
  • Brains4Viruses
  • CEPI
  • COMPARE
  • CORSURV
  • CRIP
  • DELTA-FLU
  • DUCAMID (NWO Caribbean)
  • ECRAID-plan
  • EFSA NGS Noro
  • EFSA Wild
  • EHVA
  • Epitope Mapping
  • EVAg
  • EVDLabNet
  • FLUCOP
  • INITIATE ETN Marie Curie
  • METASTAVA
  • Mrace, Innovative HIV prevention strategies based on transmission networks in Rotterdam
  • Mrace, Treatment for chronic norovirus infections
  • Nophame, Marie Curie IF
  • NWA-ORC Preparing for vector-borne virus outbreaks in a changing world: a One Health Approach
  • PREPARE
  • RECODID
  • RIVM - ECDC Surveillance
  • RIVM emerging infections
  • RIVM Flu Research
  • SHARP 
  • Simon Stevin
  • Single cell T-cell
  • STW Environmental safety
  • Support Casper
  • VetBioNet
  • Vidi Respiratory Viruses
  • Vidi, Identifying determinants of respiratory virus transmission between mammals
  • ZAPI (IMI )
  • ZIKAlliance
  • ZikaRisk
  • Zoonoses in the night

Notable results

Societal relevance results

  • Discovery of the human metapneumovirus, MERS CoV, and others.
  • The identification of camels as the reservoir for MERS CoV.
  • Basic insights into how avian influenza viruses and other zoonoses cause diseases in humans.
  • Unravelling how avian influenza viruses can become transmissible for humans.
  • Discovery of mechanism of norovirus evolution and its impact on population health.
  • Support to WHO as collaborating centre for emerging viral infections.

Collaboration

ECO Health Alliance - The Department of Virology is closely involved in the Eco Health Alliance. 

NCOH - The Department of Viroscience is one of the founding partners of NCOH, in addition to Utrecht University, Wageningen University & Research Centre, University Medical Center Utrecht and Academic Medical Centre Amsterdam.

NORONET - The Department of Virology of the Erasmus MC is partner of NoroNet., an informal network of scientists working in public health institutes or universities sharing virological, epidemiological and molecular data on the norovirus. 

OVIT Consortium - De OVIT consortium is a Dutch consortium focused on delivering effective solutions in pancreatic cancer; a multidisciplinary team that includes virologists, paediatric oncologists and neurosurgeons from Erasmus MC, LUMC and UMC Utrecht.

RODIN - Regional Rotterdam Infectious Diseases Network

Events and awards

In the media

Corona and other viruses in the media

‘Corona-college’ voor Feyenoord-selectie na testochtend
Feyenoord 1  07 augustus 2020 13:18 clubarts Casper van Eijck, virologe Annemiek van der Eijk en IC-arts Diederik Gommers.

Wat lifter mee in ons bloed?
hetnatuurhistorischmuseum.nl Programma 20-09-2020, Rik de Swart

Miljarden puzzelstukjes tegen corona
Labtechnology, 06-08-2020, Marion Koopmans

Is er sprake van een tweede golf?
NRC, 05-08-2020, Marion Koopmans

Extra Digitale Editie over de coronacrisis als traumaverwerking. Of als voorbereiding op fase 2
de Volkskrant, 02-08-2020, Bart Haagmans

Vies, maar belangrijk werk: Virologen speuren naar corona in ontlasting van Rotterdammers
Algemeen Dagblad, 28-07-2020, Miranda de graaf

Uitbraak coronavirus onder Rotterdamse studenten
Algemeen Dagblad, 27-07-2020, Marion Koopmans

Zelfs in celkweek werkt chloroquine niet
NRC, 22-07-2020, Bart Haagmans

Forse stijging van aantal nieuwe coronabesmettingen
NRC, 21-07-2020, Marion Koopmans

Het virus is klaar’, en andere dwarse ideeën
De Volkskrant, 21-07-2020, Marion Koopmans

‘Risico voor publiek groter dan voor sporters’
BN De Stem, 17-07-2020, Marion Koopmans

Corona-aanpak | Marion Koopmans, viroloog 
BNR Webredactie, 16 juli 2020, 

Kunnen wetenschappers binnenkort een nieuwe uitbraak van infectieziektes voorspellen?
NPO radio 1, 15-07-2020, Marion Koopmans

Viroloog Erasmus MC leidt groot project naar opsporing infectieziektes
Rijnmond Nieuws, 15-07-2020, Marion Koopmans

Onderzoek: antistoffen snel weg
de Volkskrant, 14-07-2020, Marion Koopmans

Steekmuggenoverlast melden via de landelijke muggenradar
Friesch dagblad, 11-07-2020, afd. Viroscience EMC

Hoe tech het post-coronatijdperk vormgeeft
Emerce.nl, 11-07-2020, Ron Fouchier

Nieuw inzicht in afweer tegen corona
www.medicalfacts.nl,  29-06-2020, Rory de Vries

Genetici zitten coronavirus op de hielen
nrc.nl, 26-06-2020, Bas Oude Munnink

Het coronavirus lijkt onder controle, maar is het niet te vroeg om te juichen?
NPO1, OP1, 08-06-2020, Marion Koopmans

Tentoonstelling 'Vaccineren Ja!/Nee?'verlengd, met corona-update
www.hetnatuurhistorisch.nl, 09-06-2020, Rik de Swart, Bart Haagmans, Marion Koopmans

Antistof in strijd tegen corona ingezet
zorgkrant.nl, 09-06-2020, Bart Haagmans

Koopmans na daling coronadoden: virus is zeker nog niet weg
Nieuws.nl, 17 May 2020, Marion Koopmans

Ons voedselsysteem is een roulette
bnnvara.nl, Joop, 17 May 2020, Ron Fouchier

Opschalen vaccinproduktie wordt het grote probleem
Bionieuws, 16 May 2020, Ron Fouchier, Ab Osterhaus

Pandemieproof de toekomst in
Bionieuws, 16 May 2020, Ron Fouchier

Kan de airco op kantoor het coronavirus verspreiden?
Trouw, 16 May 2020, Ron fouchier

Viroloog Marion Koopmans verwacht nieuwe coronagolf
www.nationalezorggids.nl, 11 May 2020, Marion Koopmans

Als alles meezit: over 5 maanden medicijn tegen corona
NPOradio1.nl, 11 May 2020, Bart Haagmans

Veel vragen rond mogelijk nieuwe kinderziekte
nu.nl, 1 May 2020, Pieter Fraaij

Duitse virologen: 'Kinderen ook besmettelijk, wees voorzichtig met openen scholen'
nos.nl, 30 April 2020, Marion Koopmans

Wel of niet een mondkapje: deze vier kwesties gaan de wereld na de lockdown bepalen
de Volkskrant, 30 April 2020, Marion Koopmans, Sander Herfst

Niet de nerst, maar de mens is gevaarlijkste besmetter
NRC, 28 April 2020, Ron Fouchier, Sander Herfst

Onderzoek Erasmus MC bevestigt: corona via lucht overdraagbaar
de Stentor, 26 April 2020, Sander Herfst

Waarom Rotterdamse virologen talkshows én onderzoek domineren
Erasmus Magazine, 23 April 2020

Waarom zijn kinderen minder besmettelijk? Annemiek van der Eijk geeft antwoord.
Jeugdjournaal, 22 April 2020, Annemiek van der Eijk

Vormen dierenmarkten wereldwijd een risico voor nieuwe pandemiën?
de Volkskrant, 22 April 2020, Thijs Kuiken

Team Casper van Eijk actief bij corona-onderzoek
Goudsdagblad.nl, 17 April 2020, Ron Fouchier

Valse testen
NRC, 17 April 2020, Marion Koopmans

SARS-CoV-2 besmettelijker door vermenigvuldiging in neus en longen
blikopnieuws.nl, 17 April 2020, Marion Koopmans

Antistoffen tegen coronavirus bij 3 procent Nederlanders, wat betekent dat?
nos nieuws, 16 April 2020, Marion Koopmans

'Heilig' team bepaalt ons dagelijks leven
Algemeen Dagblad, 16 April 2020, Marion Koopmans

Stap van Trump uit WHO kan als boomerang terugkomen
nos.nl, 15-04-2020, Marion Koopmans

Onderzoek is hand aan de kraan
De Groen Amsterdammer, 15 April, 2020, Marion Koopmans

Corona-zelftests: Zijn ze betrouwbaar?
gezondheidsmet.nl, 15 April 2020, Ron Fouchier

Kun je meerdere keren Corona krijgen?
de Volkskrant, 14 April 2020, Bart Haagmans

Koopmans en Haagmans over coronacrisis:'Dit moest gewoon een keer gebeuren"
De Limburger, 11 April 2020, Bart Haagmans en Marion Koopmans

Februari: de verloren maand in de strijd tegen het coronavirus
de Volkskrant, 11 April 2020, Marion Koopmans

Lex Bohlmeijer- In gesprek met Marion Koopmans. Pandemie (2)
de Correspondent, 10 April 2020, Marion Koopmans

Wie zijn de coronabeslissers in Nederland
Trouw, 9 April 2020, Marion Koopmans

Eind April heel voorzichtig een eerste stap
NPO radio 1, 1 op 1, 9 April, 2020, Marion Koopmans

Corona-exitstrategiën
BNR radio, ask me anything, 8 April 2020, Eric van Gorp

Is het nu te laat?
De Groene Amsterdammer, 8 April 2020, Marion Koopmans

Milde coronaklachten lijken minder antistoffen op te leveren. Wat betekent dat?
NOS nieuws, 8 April 2020, Marion Koopmans

Erasmus MC: Geschikte kandidaat-immuuntest voor coronavirus
NOS Nieuwsuur, 6 April 2020, Marion Koopmans

Een precaire balans
Leeuwarder Courant, 5 April 2020, Pieter Fraaij

Corona daagt ons uit.
Max vandaag, 6 April 2020, Eric van Gorp

Nederland is vol met gastheren die een virus over kunnen dragen
AD, 5 April 2020, Ron Fouchier

Veelbelovend vaccin tegen COVID-19 op muizen getest
scientas.nl, 2 April 2020, Bart Haagmans

Marion Koopmans over traceerapp in NRC
www.eur.nl, 3 April 2020, Marion Koopmans

Waarom corona-thuistesten niet betrouwbaar zijn
Nemo Kennislink, 3 April 2020, Ron fouchier

Hou ritme tegen corona
maxvandaag.nl, 2 april 2020, Eric van Gorp

Omroep MAX werkt samen met topwetenschappers
Bouwen aan de zorg, 2 April 2020, Eric van Gorp

Interview, Tijd voor MAX,
NPO1, 31 March 2020, Eric van Gorp

Reggeborgh schenkt 50.000 euro voor corona-onderzoek
destentor.nl, 31 March 2020, Bart Haagmans

Een vaccin tegen coronavirus niet binnen een jaar verwacht
ad.nl, 31 March 2020, Bart Haagmans

Wanneer ben je beschermd tegen het coronavirus?
kijknieuws.nl, 27 March 2020, Marion Koopmans

Spliterwten en Slaolie
nrc.nl, Martijn Katan, 27 March 2020, Ron Fouchier

Immuniteit tegen virus vervaagt al na een paar jaar
Trouw, 27 March 2020, Marion Koopmans

COVID-19 webinar krijgt vervolg
vphuisartsen.nl, 25 March 2020, Eric van Gorp

Langzaam richting smoren
de Groene Amsterdammer, 25 March 2020, Marion Koopmans

Wel of niet doen? Buiten spelen in de tijd van coronacrisis.
indebuurt.nl, 23 March 2020, Bart Haagmans

Carolien krijgt reacties uit de hele wereld op corona-onderzoek
De Twensche Courant Tubantia ed. Reggestreek, 23 March 2020, Carolien van der Sandt

Virus van morgen
NPO 2, VPRO Tegenlicht, 22 March 2020, Ron Fouchier

Leerlingen Walburg College krijgen les in virology
hendrik-ido-ambacht.dekombinatie.nl, 21 March 2020, viruskenner

Het is officieel lente, maar de winter heeft een verlaat staartje
rtlnieuws.nl, 20 March 2020, Bart Haagmans

Interview Nieuws en Co
NPO Radio 1, 19 March 2020, Marion Koopmans

Een vaccine voor het coronavirus laat nog zeker een jaar op zich wachten
drimble.nl, 19 March 2020, Bart Haagmans

Landelijke bloedtest om te zien of in Nederland immuniteit tegen corona ontstaat?
parool.nl, 19 March 2020, Marion Koopmans

Mag een kankerpatiënt bezocht worden en kan een 80-jarige nog de deur uit?
NOS.nl, 18 March 2020, Annemiek van der Eijk

Mexicaanse of Spaanse griepvirus: welk scenario volgt het coronavirus?
geotrendlines.nl, 18 March 2020, Marion Koopmans

Interview Nieuwsuur
NPO 2, Nieuwsuur, 18 March 2020, Marion Koopmans

Wat moet een virus doen om een pandemie te veroorzaken?
Quest, 17 March 2020, Marion Koopmans, Ron Fouchier

Hoe gevaarlijk kan een pandemie worden?
Newsmonkey.be, 17 March 2020, Ron Fouchier

Luchtruim en scholen sluiten weinig zin als horeca openblijft
Caribischnetwerk.ntr.nl, 16 March 2020, Byron Martina

Interview Eén Vandaag
NPO 1,  16 March 2020, Marion Koopmans 

Misverstand over coronavirus: "Niet alleen ouderen worden ziek, ook jongeren"
RTLNieuws, 16 March 2020

Omgaan met de corona-lockdown
BNR-Ask Me Anything, podcast, 16 March 2020, Eric van Gorp

Extra lange uitzending over coronacrisis
hartvannederland.nl, 15 March 2020, Marion Koopmans

Nederland steunt rigoureuze maatregelen kabinet in strijd tegen coronavirus
hartvannederland.nl, 15 March 2020, Marion Koopmans

Annemiek van der Eijk geeft antwoord op de vragen van kinderen
NPO 3, Jeugdjournaal, 15 March 2020, Annemiek van der Eijk

Stamboom toont pad van het virus
NRC Handelsblad, 14 March 2020

Zijn we af van corona als het straks zomer wordt?
de Volkskrant, 13 March 2020, Ron Fouchier
 
Verspreiding en aanpak van het coronavirus
WNL, Goedemorgen Nederland, 13 March 2020, Marion Koopmans

Marathon Rotterdam, Gold Race en GP Zandvoort ook in het gedrang?
Algemeen Dagblad, 10 March 2020, Marion Koopmans

Jounaal 07.00 uur
NPO 1 Radio journaal. 10 March 2020, Eric van Gorp

Kan uw huisdier ook besmet raken met coronavirus?
www.maxvandaag.nl, 10 March 2020, Thijs Kuiken

Vijf minuten met Marion Koopmans
NPO radio 1, 9 March 2020, Marion Koopmans

60 nieuwe coronabesmettingen, de meeste in Brabant. Wat is er aan de hand?
Trouw, 7 March 2020, Marion Koopmans

Belangrijkste verschil met griep is dat er voor coronavirus geen vaccin is.
NOS.nl, 2 March 2020, Eric van Gorp

Updates, nieuwe besmettingen in Nederland
BNR.nl, 2 March 2020, Eriv van Gorp

Wat gebeurt er als het coronavirus het lichaam binnendringt?
de Volkskrant, 3 March 2020, Bart Haagmans

Chloroquine is nog 'geen' wondermiddel
de Stentor, 29 Februari 2020, Bart Haagmans

A completely new culture of doing research. Coronavirus outbreak changes how scientists communicate
Science Magazine, 26 Februari 2020, Marion Koopmans

Q and A with Marion
NOS, 26 Februari 2020, Marion Koopmans

Pandemic prep: What you should know to protect against coronavirus
New York Post, 25 Februari 2020, Marion Koopmans

'Ik zou zó het vliegtuig naar China pakken'
NPO radio 1, 1 op 1, 31 Januari 2020, Marion Koopmans

Reageert Nederland té ontspannen?
NPO radio 1, Spraakmakers, 28 Januari 2020

De wereld houdt de adem in
Mens & Molecule, 26 Februari 2020, Marion Koopmans

Draaiboeken liggen klaar mocht coronavirus in Nederland opduiken
WNL op zaterdag, 25 Januari 2020, Marion Koopmamns

 

 

Overige berichten:

Nationale Griepprikdag
MaxVandaag, 11 November 2019

Duizenden wetenschappers roepen 'klimaatnoodtoestand' uit
MSN, 7 November 2019

Mazelen nóg schadelijker dan gedacht
BNR, 3 November 2019

Na mazelen is afweersysteem landurig afgezwakt
NPO Radio 1, 1 November 2019

Mazelen wissen geheugencellen afweersysteem
Vakblad Vroeg, 1 November 2019

Hoe de zorg zich schrap zet voor de horrorgriep
de Volkskrant, 1 November 2019

Griepprikken door vertraging met vaccins later gezet
de Gelderlander, 24 October 2019

Vrij onderzoek is cruciaal. Investeer er dan ook in
NRC, 11 October 2019

Straatvraag: Haal jij de griepprik
Rijnmond Nieuws, 8 October 2019

10 million for One Health research in the Netherlands
Erasmus MC, 12 juni 2019

Measles erases the immune system’s memory
ScienceNews, 21 May 2019

Kunnen mensen dieren ziek maken?
NRC, 17 May 2019

Disease X is not science fiction
NCOH, 17 May 2019

Marion Koopmans lunched with Royal couple
NOS, 9 May 2019

Marion Koopmans elected as KNAW member
KNAW, 24 April 2019

Measles Cases Continue to Soar, Stirring Concern Over Long-Term Effects 
The Wall Street Journal, 15 April 2019

Taking Emerging Infections to Task
Elsevier, 12 April 2019

 

Awards and grants

Recent awards and grants within our department:

  • Prof. Marion Koopmans: NWA-ORC Preparing for vector-borne virus outbreaks in a changing world: a One Health Approach. June 2019. Read all about it.
  • Prof. Marion Koopmans: Marion Koopmans elected as KNAW member. April 2019. Read all about it.
  • Dr. Rory de Vries: Beijerink Virology Prize awarded by the Royal Netherlands Academy of Arts and Sciences. January 2019. Read all about it.
  • Dr. Sander Herfst: The Heine-Medin Award 2018 granted by the European Society of Clinical Virology. October 2018. Read all about it.
  • Prof. Marion Koopmans: NWO Stevin Prize, the highest distinction in Dutch science. September 2018. Read all about it.
  • Prof. Marion Koopmans: honorary doctorate from the Technical University of Denmark (DTU). September 2018. Read all about it.
  • Debby van Riel: Vidi-grant by the Netherlands Organisation for Scientific Research (NWO). Awarded June 2018. Read the NWO press release.
  • Debby van Riel named member of the Young Erasmus Academy by the Erasmus Universiteit Rotterdam. March 2018. Read all about it. (Dutch)
  • My Phan: Marie Curie Individual Fellowship. March 2018. Read all about it.
  • Prof. Guus Rimmelzwaan: Alexander von Humboldt Professorship, the most extensive German grant awarded to scientific research. May 2017. Read our press release. (Dutch)
  • Prof. Ron Fouchier: Huibregtsen Prize for top innovative science with societal impact. October 2013. Read all about it.
  • Prof. Ron Fouchier: named one of the world's 100 Most Influential People by Time Magazine. 2012. Read all about it.

Career opportunities

Vacancies

Any questions?

Please contact our office if you have any questions or comments.

Contact